Apollo Hospitals Enterprise Ltd (APOLLOHOSP)

Apollo Hospitals' Dividend Set to Increase in 2025 - 23 Jul, 2024

Apollo Hospitals Enterprise is set to increase its dividend to Rs 10.00 on January 1, with a projected payout ratio of 9.6% by next year. MD Suneeta Reddy discusses the budget's impact on healthcare.

Apollo Hospitals Group Urges Robust Healthcare Sector in Upcoming Union Budget - 20 Jul, 2024

Suneeta Reddy, MD of Apollo Hospitals Group, emphasized the need for significant investments in India's healthcare infrastructure to achieve the 5 trillion dollar economy goal. She suggested granting national priority status to the healthcare sector and boosting domestic manufacturing of medical devices through tax incentives and regulatory support. Vikram Thaploo, CEO-Telehealth at Apollo Hospitals Enterprises Limited, also called for a budget that strengthens the healthcare foundation of the country.

Apollo Hospitals Receives Buy Call from HDFC Securities - 12 Jul, 2024

HDFC Securities has given a buy call on Apollo Hospitals Enterprise with a target price of Rs 7250. Additionally, Apollo is expected to maintain its stable occupancy rate while achieving 6% YoY growth in ARPOB.

Apollo Hospitals Enterprise Expected to See Robust Growth - 11 Jul, 2024

Apollo Hospitals Enterprise is projected to see earnings growth of 33.2% annually over the next three years, outpacing the Indian market. Despite revenue growth forecast not reaching high-growth threshold, it still exceeds the market average. The company's Return on Equity is also anticipated to be strong at 23.4%. Recently expressed interest in acquiring Jaypee Healthcare.

Apollo Hospitals Enterprise Explores Growth Through Acquisitions - 10 Jul, 2024

Apollo Hospitals Enterprise is exploring growth through strategic acquisitions, including Jaypee Healthcare. The company reported a significant increase in annual revenue and net income for FY2023-24. Challenges include executive changes and maintaining growth momentum amidst aggressive expansion plans.

Apollo Hospitals Enterprise Shows Robust Growth Potential Amid Strong Financial Performance - 09 Jul, 2024

Apollo Hospitals Enterprise demonstrates strong financial performance and proactive market stance through strategic acquisitions and digital health expansion. MOFSL forecasts significant YoY growth in Q1FY25 net profit, gross sales, and EBITDA.

Apollo Hospitals Pursues Strategic Growth Amid Bankruptcy Proceedings - 08 Jul, 2024

Apollo Hospitals Enterprise's recent interest in acquiring Jaypee Healthcare amidst bankruptcy proceedings reflects its dynamic approach to expanding core and digital health services. Additionally, a fresh breakout has been observed above the Cup & Handle pattern on daily charts of Apollo Hospitals stock, indicating positive price action.

Apollo Hospitals Invests in Subsidiary AHLL - 07 Jul, 2024

Apollo Hospitals Enterprises is set to acquire a stake worth Rs 103.26 crore in its subsidiary, Apollo Health and Lifestyle Limited (AHLL), through a rights issue. The investment aims to strengthen AHLL's business operations, working capital, and expansion initiatives.

Apollo Hospitals Enterprise Ltd Share Price Up by 373% in Last Five Years - 05 Jul, 2024

Investing in Apollo Hospitals Enterprise five years ago would have delivered a 380% gain. The company's earnings per share grew at 30% annually, and its TSR for the last 5 years was 380%, largely due to dividend payments.

Apollo Hospitals Shows Bullish Divergence on Charts - 04 Jul, 2024

Technical analysis suggests a potential reversal from downtrend to uptrend for Apollo Hospitals Enterprise Ltd. A bullish divergence on the 1-hour chart and a double bottom pattern at the 200-day Exponential Moving Average on the daily chart indicate a trend change.

Apollo Hospitals Enterprise Stock Shows Bullish Reversal - 29 Jun, 2024

After a period of depreciation, Apollo Hospitals Enterprise stock has been moving up since June. The stock crossed over both 20- and 50-day moving averages and breached trendline resistance. A double bottom pattern confirms bullish reversal.

Macquarie Maintains Underperform Rating on Apollo Hospitals - 26 Jun, 2024

Global investment bank Macquarie has maintained an underperform rating on Apollo Hospitals Enterprise Ltd due to rate hikes driving top-line growth, while volume growth moderates. The bank believes that organic bed capacity additions in the next three years will pressure profitability. Macquarie's earnings estimates for the company are 9-22% below consensus.

Apollo Hospitals Receives Positive Ratings from Kotak Securities and Expands into Diagnostics Space - 24 Jun, 2024

Apollo Hospitals receives an ADD rating from Kotak Securities with a target price of Rs 6735 and is set to expand its presence in the diagnostics space. The company aims to create a retail healthcare powerhouse with Apollo Healthco and has received praise for its Keimed merger.